320 related articles for article (PubMed ID: 25533384)
1. Tuberous sclerosis complex: the past and the future.
De Waele L; Lagae L; Mekahli D
Pediatr Nephrol; 2015 Oct; 30(10):1771-80. PubMed ID: 25533384
[TBL] [Abstract][Full Text] [Related]
2. Current management of tuberous sclerosis complex.
Krueger DA; Franz DN
Paediatr Drugs; 2008; 10(5):299-313. PubMed ID: 18754697
[TBL] [Abstract][Full Text] [Related]
3. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
Roth J; Roach ES; Bartels U; Jóźwiak S; Koenig MK; Weiner HL; Franz DN; Wang HZ
Pediatr Neurol; 2013 Dec; 49(6):439-44. PubMed ID: 24138953
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Curatolo P
Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
[TBL] [Abstract][Full Text] [Related]
5. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.
Jóźwiak S; Nabbout R; Curatolo P;
Eur J Paediatr Neurol; 2013 Jul; 17(4):348-52. PubMed ID: 23391693
[TBL] [Abstract][Full Text] [Related]
6. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
[TBL] [Abstract][Full Text] [Related]
7. Renal tumors in tuberous sclerosis complex.
Trnka P; Kennedy SE
Pediatr Nephrol; 2021 Jun; 36(6):1427-1438. PubMed ID: 33006051
[TBL] [Abstract][Full Text] [Related]
8. Possible prevention of tuberous sclerosis complex lesions.
Kotulska K; Borkowska J; Jozwiak S
Pediatrics; 2013 Jul; 132(1):e239-42. PubMed ID: 23733802
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system manifestations of tuberous sclerosis complex.
Lu DS; Karas PJ; Krueger DA; Weiner HL
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):291-298. PubMed ID: 30230171
[TBL] [Abstract][Full Text] [Related]
10. Managing tuberous sclerosis in the Asia-Pacific region: refining practice and the role of targeted therapy.
Lawson JA; Chan CF; Chi CS; Fan PC; Kim HD; Kim KJ; Likasitwatanakul S; Ortiz M; Riney K; Tay SK; Tham CK
J Clin Neurosci; 2014 Jul; 21(7):1180-7. PubMed ID: 24518266
[TBL] [Abstract][Full Text] [Related]
11. Description of a multidisciplinary model of care in a French cohort of adult patients with tuberous sclerosis complex.
Pfirmann P; Aupy J; Jambon E; Idier L; Prezelin-Reydit M; Fermis M; Devillard R; Grenier N; Combe C; Rigothier C
J Med Genet; 2021 Jan; 58(1):25-31. PubMed ID: 32409510
[TBL] [Abstract][Full Text] [Related]
12. Cross-sectional Imaging Review of Tuberous Sclerosis.
Krishnan A; Kaza RK; Vummidi DR
Radiol Clin North Am; 2016 May; 54(3):423-40. PubMed ID: 27153781
[TBL] [Abstract][Full Text] [Related]
13. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
[TBL] [Abstract][Full Text] [Related]
14. Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management.
Samueli S; Abraham K; Dressler A; Groeppel G; Jonak C; Muehlebner A; Prayer D; Reitner A; Feucht M;
Wien Klin Wochenschr; 2015 Aug; 127(15-16):619-30. PubMed ID: 25860851
[TBL] [Abstract][Full Text] [Related]
15. Analysis of twenty pediatric cases of tuberous sclerosis complex: are we doing enough?
Nath J; Dubey A; Pavan R
Indian J Dermatol Venereol Leprol; 2015; 81(1):23-8. PubMed ID: 25566892
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for the management of renal involvement in the tuberous sclerosis complex.
Ariceta G; Buj MJ; Furlano M; Martínez V; Matamala A; Morales M; Robles NR; Sans L; Villacampa F; Torra R
Nefrologia (Engl Ed); 2020; 40(2):142-151. PubMed ID: 31722796
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of Sporadic Versus Tuberous Sclerosis Complex-Associated Angiomyolipoma.
Rabenou RA; Charles HW
AJR Am J Roentgenol; 2015 Aug; 205(2):292-301. PubMed ID: 26204278
[TBL] [Abstract][Full Text] [Related]
18. New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex.
Lam HC; Nijmeh J; Henske EP
J Pathol; 2017 Jan; 241(2):219-225. PubMed ID: 27753446
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.
Franz DN; Belousova E; Sparagana S; Bebin EM; Frost M; Kuperman R; Witt O; Kohrman MH; Flamini JR; Wu JY; Curatolo P; de Vries PJ; Whittemore VH; Thiele EA; Ford JP; Shah G; Cauwel H; Lebwohl D; Sahmoud T; Jozwiak S
Lancet; 2013 Jan; 381(9861):125-32. PubMed ID: 23158522
[TBL] [Abstract][Full Text] [Related]
20. Renal manifestations of tuberous sclerosis complex.
O'Hagan AR; Ellsworth R; Secic M; Rothner AD; Brouhard BH
Clin Pediatr (Phila); 1996 Oct; 35(10):483-9. PubMed ID: 8902325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
